CryoLife, Inc. (NYSE:CRY)
CAPS Rating:
The Company develops and commercializes biomaterials, implantable medical devices, and preserves and distributes human tissues for cardiovascular and vascular transplant applications.
RSS Headlines
Fool UK
Recs
This pick is pure speculation.